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Abstract
Accumulation of prion protein (PrPSc) in the central nervous system is the hallmark of transmissible spongiform
encephalopathies. However, in some of these diseases such as scrapie or chronic wasting disease, the PrPSc can also
accumulate in other tissues, particularly in the lymphoreticular system. In recent years, PrPSc in organs other than nervous
and lymphoid have been described, suggesting that distribution of this protein in affected individuals may be much larger
than previously thought. In the present study, 11 non-nervous/non-lymphoid organs from 16 naturally scrapie infected
sheep in advanced stages of the disease were examined for the presence of PrPSc. Fourteen infected sheep were of the
ARQ/ARQ PRNP genotype and 2 of the VRQ/VRQ, where the letters A, R, Q, and V represent the codes for amino-acids
alanine, arginine, glutamine and valine, respectively. Adrenal gland, pancreas, heart, skin, urinary bladder and mammary
gland were positive for PrPSc by immunohistochemistry and IDEXX HerdChek scrapie/BSE Antigen EIA Test in at least one
animal. Lung, liver, kidney and skeletal muscle exhibited PrPSc deposits by immunohistochemistry only. To our knowledge,
this is the first report regarding the presence of PrPSc in the heart, pancreas and urinary bladder in naturally acquired
scrapie infections. In some other organs examined, in which PrPSc had been previously detected, PrPSc immunolabeling
was observed to be associated with new structures within those organs. The results of the present study illustrate a wide
dissemination of PrPSc in both ARQ/ARQ and VRQ/VRQ infected sheep, even when the involvement of the lymphoreticular
system is scarce or absent, thus highlighting the role of the peripheral nervous system in the spread of PrPSc.
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Introduction
Transmissible spongiform encephalopathies (TSEs; also known
as prion diseases) are a group of neurodegenerative diseases that
affects humans and animals. The main feature of these diseases is
the deposition of a misfolded form of the prion protein (hereafter
referred to as PrPSc) in the central nervous system (CNS). In some
TSEs, including scrapie in sheep and goats, chronic wasting
disease (CWD) in deer and variant Creutzfeldt-Jakob disease
(vCJD) in humans, PrPSc has been detected in diverse tissues and
organs outside the CNS [1,2].
Scrapie was the first TSE to be identified and is considered to be
the archetype of this group of diseases. In naturally acquired
scrapie, evidence suggests that the main route of entry of the agent
is through the gut-associated lymphoid tissues, which then spreads
to the CNS by centripetal transport along the peripheral nervous
system (PNS; [3,4]). However, the scrapie agent may also
propagate to other organs; PrPSc deposits in natural scrapie
infections have been detected in placenta [5], skeletal muscle [6],
kidney [7,8], skin [9] and liver [10]. In addition, PrPSc has also
been associated with inflammation foci in different organs such as
the lung and mammary glands from scrapie infected sheep
[11,12,13].
Tissue distribution of the scrapie agent may be influenced by
several different factors including host genetics, the dose of the
infectious agent and the strain of the agent [1,14,15]. The ovine
PRNP genotype determines susceptibility to scrapie and is one of
the best studied factors known to affect the spread of the scrapie
agent. The ancestral PRNP gene encodes for the amino-acids
alanine (A), arginine (R) and glutamine (Q) at codons 136, 154 and
171 (hereafter referred to as haplotype ARQ) and it is the most
common haplotype found in Spanish ovine breeds [16]. Polymor-
phisms at codons 136 (substitution of A by valine (V); haplotype
VRQ) and 171 (substitution of Q by R; haplotype ARR) are
associated with an increased susceptibility or resistance to sheep
scrapie, respectively. The majority of studies addressing the spread
of infection through the body in naturally acquired scrapie use
sheep carrying the most susceptible genotype (VRQ/VRQ), which
are associated with wide PrPSc dissemination throughout the sheep
[17]. In ARQ/ARQ scrapie infected sheep, the degree of the
systemic spread of infection is less clear. It appears that ARQ/
ARQ and VRQ/ARQ sheep develop natural scrapie with longer
incubation periods and less dissemination of PrPSc than VRQ/
VRQ sheep [18,19,20]. Here, we examined the main character-
istics and tissue distribution of PrPSc in organs outside the CNS
and LRS from scrapie infected ARQ/ARQ sheep. We used
naturally infected animals and conventional methods for PrPSc
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e97768
detection (i.e., immunohistochemistry) that reflect the pathophys-
iology and transmission of the disease better than other
experimental models or ultrasensitive PrPSc detection techniques
[1,21].
Materials and Methods
Animals
The study population included 16 scrapie infected sheep from 7
scrapie outbreaks detected within the framework of the Spanish
TSE surveillance program. Animals were selected upon exhibition
of clinical signs compatible with scrapie [22], and infection was
confirmed post-mortem by PrPSc immunodetection in the
brainstem at the level of the obex (hereafter referred to as
brainstem). With two exceptions, all animals displayed the ARQ/
ARQ genotype and were of the Rasa Aragonesa breed or a cross
breed.
Ten control sheep were selected from flocks in which no scrapie
cases have been reported to date, and these sheep died of different
causes other than scrapie. Animals were confirmed to be negative
for scrapie by using immunohistochemistry (IHC) to detect the
presence of PrPSc in lymphoid tissue and the CNS. Individual
details of sheep used in this study are provided in Tables 1 (scrapie
infected sheep) and S1 (control sheep).
This study was approved by the Ethics Committee for Animal
Experiments of the University of Zaragoza (Permit Number:
PI02/08) and was carried out in strict accordance with the
recommendations for the care and use of experimental animals
and in agreement with the national legislation (R.D. 1201/2005).
Tissue Collection
Infected animals were euthanized by intravenous injections of
sodium pentobarbital and exsanguination, and the necropsy was
performed immediately. The following organs were collected from
each sheep: brain, palatine tonsils, spleen, ileum, heart, lung,
pancreas, liver, adrenal gland, kidney, urinary bladder, ovary,
uterus, skin and skeletal muscle. Except for palatine tonsils and
ileum, all tissues were divided into two halves. One half was
formalin-fixed and paraffin-embedded for further histopatholog-
ical analysis, and the other half was frozen and stored at 280uC
until used for the IDEXX HerdChek scrapie/BSE Antigen EIA
Test. Palatine tonsils and ileum (Peyer’s patch) were examined
only by IHC.
Immunohistochemistry
Formalin-fixed tissues were trimmed and processed according to
standard histopathological procedures. A 4 mm tissue section from
each sample was stained with haematoxylin and eosin for
microscopic examination.
For PrPSc detection by IHC, 3 serial tissue sections (4 mm)
spaced 200 mm apart were obtained and assessed as previously
described [23]. Briefly, sections were pre-treated with 98% formic
acid, proteinase K (4 mg/ml; F. Hoffmann La Roche Ltd, 211
Switzerland) and hydrated autoclaving. Then, tissue sections were
incubated with a blocking reagent and immunolabeled using an
automated immunostainer. Sections were incubated with an L42
primary antibody (0.046 mg/ml; R-Biopharm, Darmstadt, Ger-
many) at room temperature for 30 minutes. EnVision was used as
a visualisation system and diaminobenzidine as the chromogen.
Finally, sections were counterstained with haematoxylin. If
necessary, PrPSc immunostaining with antibody L42 was con-
firmed by immunostaining with the monoclonal antibody F89
(0.5 mg/ml; NC-Neopharma) using the protocol describe above.
Unless stated otherwise, all products were obtained from Dako
(Denmark A/S, Denmark).
The presence/absence of PrPSc deposits and their characteris-
tics were assessed in 3 tissue sections except for the CNS and LRS
samples in which only 1 section was examined. For brainstem and
spleen samples, PrPSc signal was subjectively scored based on the
extent of immunostaining [24,25]. In the brainstem, + staining was
characterised as the accumulation of PrPSc in the dorsal motor
nucleus of the vagus nerve, ++ staining was characterised as the
accumulation of PrPSc in the dorsal motor nucleus of the vagus
nerve and the adjacent nuclei, and +++ staining was characterised
as widespread PrPSc throughout the entire section. In the spleen, +
staining was characterised as ,10% of the lymphoid follicles
containing PrPSc deposits, ++ staining was defined as 10 to 50% of
the lymphoid follicles containing PrPSc deposits, and +++ staining
was defined as .50% of the lymphoid follicles containing PrPSc
deposits.
IDEXX HerdChek Scrapie/BSE Antigen EIA Test
All samples were analysed with the ‘IDEXX HerdChek scrapie/
BSE Antigen EIA Test’ (hereafter identified as the IDEXX EIA)
according to the manufacturer’s instructions with a previous pre-
homogenization step included. Briefly, 2 grams of each frozen
sample were cut into small pieces with two scalpels until the tissue
appeared homogeneous. Three hundred mg of the sample were
placed into tissue-disruption tubes containing ceramics beads and
buffer, and were subjected to 3 cycles of homogenization in the
TeSeE Precess 48 Homogenizer (Bio-Rad). Each cycle consisted of
2 agitation phases of 45 seconds at 6500 rpm with 60 seconds of
waiting time between phases. The samples were allowed to cool for
5 minutes between cycles. One hundred and twenty ml of the
resulting homogenate was mixed with 30 ml of the diluent in the
working plate. One hundred ml of the diluted sample were transfer
to the antigen capture plate provided. The plate was agitated for 1
hour at room temperature and washed 6 times with wash solution
1. A conditioning buffer was subsequently added to each well and
incubated for 10 minutes at room temperature, and the plate was
washed again for 3 more cycles. Immobilised PrPSc was detected
by incubating the plate with a peroxidase conjugated anti-PrP
antibody and was visualised with TMB substrate. After incubating
for 15 minutes, the reaction was stopped by the addition of 1 M
hydrochloric acid, and the absorbance was read at both 450 nm
and 620 nm.
To compare the amount of PrPSc present among all animals, a
detection limit was determined for the brainstem and spleen
samples. Brainstem and spleen homogenised samples were diluted
in the buffer present in the tissue-disruption tubes (from the kit) to
obtain the following progressive dilutions: 1:4, 1:16, 1:64, 1:256,
1:1024, 1:4096, 1:16384 and 1:65416. The dilutions were
examined by the IDEXX EIA according to the manufacturer’s
instructions as previously described. The detection limit was
determined to be the last dilution at which these tissue samples
tested positive.
In the case of the 10 control sheep, only the brainstem, spleen,
liver, pancreas and urinary bladder samples were examined by
IDEXX EIA.
Results
Scrapie infection was demonstrated via the immunodetection of
PrPSc in the brainstem of 16 clinically infected sheep. By IHC, all
brainstem samples were scored as +++, and the results of the
IDEXX EIA displayed optical density (OD) values ranging from
3.438 to 4.065. The dilution series reached a detection limit
Peripheral PrPsc Distribution in Natural Scrapie
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between 1:4096 and 1:16384. Of the 16 sheep that exhibited PrPSc
accumulation in the brainstem, 14 were also positive for PrPSc in
all lymphoid tissue samples examined (palatine tonsils, ileum
Peyers Patches and spleen) and 2 were negative in all lymphoid
samples (No. 6, 7; Table 1). Positive spleen samples were further
studied: all samples exhibited ++ or +++ staining scores by IHC
and IDEXX EIA values ranged from 1.866 to 3.637 (except for
No. 15, OD 0.752). In the spleen samples, the dilution series
reached a detection limit between 1:16 and 1:256. The Individual
details of PrPSc detection by IHC and the detection limits
measured by the IDEXX EIA in the brainstem and spleen from
the scrapie infected sheep are provided in Table 1.
With regards to the other tissues, PrPSc was detected in all
organs examined except for the ovary and uterus. Adrenal gland,
pancreas, heart, skin, urinary bladder and mammary glands were
all positive by both techniques in at least one animal. Lung, liver,
kidney and skeletal muscle exhibited PrPSc deposits only by IHC,
although some OD values were close to the cut-off point set for the
IDEXX EIA. It should be noted that the cut-off point is
determined by the software kit and has been established
specifically for nervous and lymphoid tissues. In the assays
performed, the cut-off point ranged from 0.163 to 0.235.
PrPSc was not detected in samples obtained from the negative-
control sheep by either technique. Individual details of PrPSc
detection by IHC and IDEXX EIA in each organ examined are
provided in Tables 2 (scrapie infected sheep) and S2 (control
sheep).
Detection of PrPsc in the Adrenal Glands
Of the 16 animals that showed PrPSc in the CNS, 12 sheep were
positive for PrPSc in the adrenal glands based on the 2 assays used
(Table 2). By IHC, all animals exhibited PrPSc accumulation in the
adrenal glands, mostly in the medulla. Granular intracytoplasmic
labeling of chromaffin cells was observed in all cases (Fig. 1A). In
medullas with widespread PrPSc accumulation, larger PrPSc
deposits of irregular shape and short thick linear deposits were
found also associated with chromaffin cells (Fig. 1B). No PrPSc
immunolabelling was observed within medulla of adrenal glands of
uninfected control sheep (Fig. 1C). In addition to the medulla,
PrPSc was detected just beneath the capsule of the adrenal gland.
In this case, immunolabeling in the perineuronal region of the
ganglion cells (Fig. 1D) and a linear pattern thought to be
associated with nerve fibres was observed. The suprarenal
ganglion that surrounds the adrenal gland was positive when
present in the histological sample (Fig. 1E). Although intraneuro-
nal labeling was found in some ganglion cells, PrPSc was mainly
observed in the perineuronal region related to satellite cells or
neuronal processes. By IDEXX EIA testing, 12 of the 16 IHC-
positive adrenal glands exhibited OD values above the cut-off
point, displaying the highest values in comparison with all of the
other peripheral organs. In 8 cases, OD values were included in
the same range as the values obtained in spleen samples.
Detection of PrPsc in the Heart
Although only one infected sheep contained a positive heart
sample via both techniques (No. 11), 4 additional animals were
positive by IHC alone (No. 7, 8, 9, 14) and 3 additional animals
were positive via IDEXX EIA alone (No. 5, 6, 15; Table 2). One
of the IHC negative samples showed the highest OD value (No. 6;
OD 0.93).
With the exception of sheep No. 8, which displayed an
extensive area of immunolabeling, small amounts of PrPSc were
detected by IHC. In all cases, immunolabeling was located
between myocardial cells (Fig. 2A) and was often observed around
blood vessel endothelia. In sheep No. 8, Congo Red staining was
performed to detect amyloid deposits; however, a negative result
was obtained. In sheep No. 9, a markedly positive immunostaining
was also found in the epicardium and was likely associated with
vasculonervous elements. No PrPSc immunolabelling was observed
in heart of uninfected control sheep (Fig. 2B).
Detection of PrPsc in the Skeletal Muscle
By IHC, 3 sheep exhibited positive immunostaining of skeletal
muscle samples from the tongue (No. 2, 7, 11), and the other
muscles obtained from 8 sheep were also positive (No. 1–4, 7–9,
13; Table 2). With one exception (No. 8), immunolabeling was
always associated with a few small nerves inside the skeletal muscle
(1 or 2 positive nerve fibers per section). In transversal sections,
periaxonal immunolabeling could be observed in some nerve
fibres (Fig. 2C). In the case of sheep No. 8, PrPSc immunolabeling
was observed within the neuromuscular spindles, as previously
reported [6]. Neuromuscular spindles are highly innervated
structures that consist of small groups of specialized striated
muscle fibers (intrafusal fibers) surrounded by a capsule of
connective tissue. In the positive neuromuscular spindles observed
in the present study we detected PrPSc imunolabeling within
intrafusal fibers and around them (Fig. 2D); this peri-fiber
immunolabeling could be associated with the sensory nerve fibers
that are spirally arranged around the mid region of intrafusal cells.
No PrPSc immunolabelling was observed in skeletal muscle of
uninfected control sheep (Fig. 2E). By IDEXX EIA, all of the
skeletal muscle samples exhibited OD values below the cut-off,
although one sample obtained from the tongue displayed an
elevated OD value (No. 11; 0.2).
Detection of PrPsc in the Pancreas
In 2 sheep, PrPSc deposits were detected in the pancreas by IHC
and IDEXX EIA (No. 4, 8; Table 2). By IHC, 3 pancreatic tissue
samples exhibited PrPSc immunolabeling associated with struc-
tures of the PNS (No. 4, 8, 13). In these samples, intracytoplasmic
and perineuronal immunolabeling was observed in the parasym-
pathetic postganglionic neurons immersed in the pancreatic tissue
(Fig. 3A, B). Occasionally the positive neurons were located in
areas adjacent to the islet of Langerhans. A linear immunolabeling
pattern in the connective tissue septa that separates pancreatic
lobules was also observed. No PrPSc immunolabelling was
observed in pancreas of uninfected control sheep (Fig. 3C). One
of the 2 samples that tested positive by both techniques gave a high
OD value by IDEXX EIA (No. 4; OD 1.43). Two other
pancreatic samples exhibited OD values close to the cut-off point
(No. 3, 13), one of which was the remaining IHC-positive sample.
Detection of PrPsc in the Skin
Accumulation of PrPSc in the skin was detected in only one
sheep by both diagnostic techniques (No. 10; Table 2). By IDEXX
EIA testing, this sheep exhibited a highly elevated OD value (2.56)
similar to those obtained for spleen. By IHC, a granular labeling
from the stratum basale to the stratum granulosum of the
epidermis was observed and was likely associated with free nerve
endings (Fig. 4A). Similar immunolabeling was observed with the
F89 antibody (Fig. 4B). In 4 other sheep, PrPSc was detected in the
skin solely by IHC (No. 2, 4, 7, 13). In these cases, PrPSc was
associated with nerve fibres localised to the dermis as described in
the experimental models [9]. Finally, a linear immunolabeling
pattern localised to the basal side of the epithelium of the sweat
glands was also observed. This pattern, whose specificity could not
be confirmed, may be associated with the fibres that innervate
Peripheral PrPsc Distribution in Natural Scrapie
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these glands. No PrPSc immunolabelling was observed in skin of
uninfected control sheep (Fig. 4C).
Detection of PrPsc in the Urinary Bladder
In the urinary bladder, PrPSc was observed by IHC and
IDEXX EIA in a single animal (No. 8; Table 2). A weak
immunolabeling was detected in the connective tissue located
among the smooth muscle fibres of the bladder wall (Fig. 5A). As
with the previous organs, this pattern could be associated with the
nerve fibres that innervate the bladder wall. Another sheep
(No. 14) was positive only by IHC, although the OD value
obtained by IDEXX EIA was elevated (0.16). In this sample,
intracytoplasmic granular immunolabeling was found in the soma
of a parasympathetic ganglia cell immersed in the bladder wall. No
PrPSc immunolabelling was observed in urinary bladder of
uninfected control sheep (Fig. 5B).
Detection of PrPsc in the Kidney
PrPSc deposits was detected in kidney samples from 6 infected
sheep: 5 were positive by IHC only (No. 2, 4, 5, 10, 11; Table 2),
and 1 was positive by IDEXX EIA only (No. 8). Seven samples
displayed elevated OD values (range 0.10–0.21), although these
values were below the cut-off point; 3 of these samples were
positive by IHC. With one exception (No. 4), PrPSc immunolabel-
ing was consistently found in the renal papillae interstice, as
previously described [7]. In sheep No. 4, immunolabeling was
observed at the vascular pole of a renal corpuscle of a
juxtamedullary nephron in two consecutive sections (Fig. 5C).
No PrPSc immunolabelling was observed in kidney of uninfected
control sheep (Fig. 5D).
Figure 1. Immunohistochemical detection of PrPSc in adrenal glands using L42 PrP antibody. A) Adrenal medulla from a naturally scrapie-
infected sheep (x40). Granular intracytoplasmic PrPSc immunolabeling is associated with chromaffin cells (arrow). B) Adrenal medulla from a naturally
scrapie-infected sheep with an intense immunoreactivity (x20). Linear PrPSc immunolabeling can be observed also associated with chromaffin cells
(arrows). C) Adrenal medulla from an uninfected control sheep in which no PrPSc immunolabeling is present (x10). D) Adrenal capsule and cortex from
a naturally scrapie-infected sheep (x20). Perineuronal PrPSc immunolabeling is associated with neurons located beneath the capsule. E) Suprarenal
ganglion from a naturally scrapie-infected sheep with abundant granular immunoreactivity for PrPSc (x5). A detailed image of the ganglion cells is
shown in the insert picture in which PrPSc immunolabeling is observed mainly around ganglion cells.
doi:10.1371/journal.pone.0097768.g001
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Detection of PrPsc in the Mammary Gland
In the mammary gland, PrPSc was observed by IHC and
IDEXX EIA in 2 sheep (No. 9, 12; Table 2), by IHC only in 2
sheep (No. 3, 7), and by IDEXX EIA only in 1 sheep (No. 10).
The 2 animals that tested positive by both techniques, presented
PrPSc deposition in lesions associated with Maedi-visna infection
that consisted of lymphoid follicle hyperplasia (Fig. 6A). In these
sheep, viral infection was confirmed by serum antibody detection
using an ELISA test (ELITESTTM, Hyphen Biomed, Neuville sur
Oise, France). Maedi-visna antibodies were also detected in a
sheep with other lesions related to the disease (an interstitial
inflammation; No. 14) and in 2 sheep with no lesions in the
mammary gland (No. 11, 15). The 2 animals which were positive
by IHC only (No. 3, 7) exhibited periaxonal immunolabeling in
nerve fibres immersed in the interlobular connective tissue of the
mammary glands (Fig. 6C). No PrPSc immunolabelling was
observed in mammary gland of uninfected control sheep (Fig. 6B,
D).
An epithelial immunolabeling pattern characterised by granular
deposits at the basal side of the epithelium of the lactiferous ducts
was observed in 3 sheep (No. 8, 10, 14; Fig. S1A). Although this
immunolabeling pattern was no observed in mammary gland of
uninfected control sheep (Fig. S1B), its specificity could not be
demonstrated clearly because only one of these samples was
positive by IDEXX EIA (No. 10). Thus, we classified this pattern
as inconclusive by IHC.
Detection of PrPsc in the Lung
The lung samples of 4 sheep were positive by IHC, but none of
the samples were positive by IDEXX EIA. Moreover, all of the
Figure 2. Immunohistochemical detection of PrPSc in heart and skeletal muscle using L42 PrP antibody. A) Heart from a naturally
scrapie-infected sheep. PrPSc immunolabeling is located among myocardial myocytes (x63). B) Heart from an uninfected control sheep in which no
PrPSc immunolabeling is present (x40). C) Cross section of a nerve fiber bundle located within a skeletal muscle sample from a naturally scrapie-
infected sheep (x63). A periaxonal PrPSc immunolabeling can be observed in some nerve fibers (arrows). D) Skeletal muscle from a naturally scrapie-
infected sheep in which PrPSc immunolabeling is associated with a neuromuscular spindle (cross section; x63). The neuromuscular spindle was
identified by its typical structure: small groups of specialized striated muscle fibers (asterisks), which are thinner than regular muscle fibers,
surrounded by a capsule of connective tissue (arows). E) Skeletal muscle from an uninfected control sheep in which no PrPSc immunolabeling is
present (x10). A detailed image of a nerve fiber bundle immersed in the muscle is shown in the insert picture.
doi:10.1371/journal.pone.0097768.g002
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OD values were quite low (Table 2). In the positive samples, PrPSc
accumulation was associated with chronic inflammatory lesions
related to lungworm infection (No. 8, 13; Fig. 7A), Maedi-visna
infection (No. 14) or both (No. 12). Maedi-visna infection was
confirmed in sheep No. 12 and 14 by serum antibody detection as
previously described. No PrPSc immunolabelling was observed in
lung of uninfected control sheep (Fig. 7B). One sheep (No. 15)
exhibited immunolabeling in the epithelium of the bronchioles,
similar to that described in the mammary gland, which was
classified as inconclusive by IHC (Fig. S1C, D).
Detection of PrPsc in the Liver
The liver samples of 3 sheep were positive by IHC only (No. 8,
10, 11; Table 2). In these animals, PrPSc was localised to
lymphofollicular inflammatory sites around the bile ducts, in
which adult forms of Dicrocoelium were occasionally observed in the
lumen (Fig. 7C). No PrPSc immunolabelling was observed in liver
of uninfected control sheep (Fig. 7D).
One sheep (No. 2) with no inflammatory lesions showed an
immunolabeling pattern that has been previously associated with
Kupffer cells [10]. Although this sample gave a relatively elevated
Figure 3. Immunohistochemical detection of PrPSc in pancreas using L42 PrP antibody. A–B) Pancreas from naturally scrapie-infected
sheep. PrPSc immunolabeling was detected only in relation to intrapancreatic ganglia neurons, showing a granular intracytoplasmic (A; x20) or a
perineuronal (B; x40) labelling. C) Pancreas from an uninfected control sheep in which an intrapancreatic ganglion is indicated by the dotted line
(x40). No PrPSc immunolabeling is present.
doi:10.1371/journal.pone.0097768.g003
Figure 4. Immunohistochemical detection of PrPSc in skin. A–B) Skin from a naturally scrapie-infected sheep with PrPSc immunolabeling
located mainly at the epidermis. PrPSc was detected using L42 (A; x40) and F89 (B; x40) PrP monoclonal antibodies. C) Skin from an uninfected control
sheep in which no PrPSc immunolabeling is present (x40).
doi:10.1371/journal.pone.0097768.g004
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OD value, it was below the cut-off point, and we considered it to
be inconclusive by IHC (Fig. S2A, B).
Discussion
The present study reveals that in ARQ/ARQ sheep with
naturally acquired scrapie there is a wide dissemination of PrPSc
in many organs outside the CNS and LRS. Although the tropism
and distribution of PrPSc in sheep scrapie may be influenced by
the ovine genotype [26], the majority of studies addressing the
pathogenesis of naturally acquired scrapie have been performed
using highly susceptible sheep (VRQ/VRQ). In the present study,
14 ARQ/ARQ sheep were included, all of them presenting
scrapie clinical signs and a widespread PrPSc accumulation in the
CNS. Considering only the organs that were positive by both of
the PrPSc detection techniques in the same animal, 5 ARQ/ARQ
sheep showed 2 or more positive peripheral organs. In these
ARQ/ARQ sheep, in addition to being detected in the adrenal
gland, PrPSc was detected by both IHC and IDEXX EIA in the
pancreas and urinary bladder (No. 8), the pancreas (No. 4), the
mammary gland (No. 9), the skin (No. 10) and the heart (No. 11).
In sheep No. 8, 8 of the 11 peripheral organs studied were positive
by at least one technique.
To our knowledge, this is the first report describing the presence
of PrPSc in the pancreas, heart and urinary bladder in naturally
acquired scrapie. Previously, infectivity in the pancreas in natural
scrapie [26] and PrPSc accumulation in the pancreas and heart
tissue in natural CWD [27,28] has been described, although those
studies reported a different localisation pattern from that observed
in the present study. The results reported herein clearly show that
PrPSc deposits in the pancreas are associated with the PNS;
however, in natural and experimental CWD infections, PrPSc has
been observed in the islets of Langerhans [27,29]. It has been
suggested that disturbances in endocrine homeostasis that have
been described for several TSE, might be the result of targeting the
prion infection to the peripheral and/or central endocrine system
[30]. However, a relationship between the alteration of pancreatic
endocrine function and PrPSc deposition in the islets of
Langerhans has not been clearly shown [30]. Our results suggest
that PrPSc deposition in the PNS (which innervates endocrine
organs) may also participate in prion-induced endocrinopathies.
In the case of the heart, the high number of positive samples
detected was not expected (8 out of 15 were positive by at least one
Figure 5. Immunohistochemical detection of PrPSc in urinary bladder and kidney using L42 PrP antibody. A) Urinary bladder muscularis
from a naturally scrapie-infected sheep (x40). There is a weak PrPSc immunolabeling located in the connective tissue adjacent to the smooth muscle
bundles, probably associated with vasculonervous elements. B) Urinary bladder muscularis from an uninfected control sheep in which no PrPSc
immunolabeling is present (x20). The connective tissue (indicated by arrows head) with vasculonervous elements located between the smooth
muscle can be clearly seen with low magnification. C) Kidney from a naturally scrapie-infected sheep. PrPSc immunolabeling is observed mainly at the
vascular pole of a renal corpuscle (x40). D) A renal corpuscule of a kidney from an uninfected control sheep in which no PrPSc immunolabeling is
present (x20).
doi:10.1371/journal.pone.0097768.g005
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technique), because the presence of PrPSc and its infectivity had
not been previously reported in natural scrapie. In experimental
and natural CWD, PrPSc deposits have been associated with
cardiac muscle cells [28,29]; however, our results show that
immunolabeling of PrPSc is located between myocardial cells
containing an extensive network of capillaries. Thus, PrPSc
distribution in the heart is similar to the pattern described in a
scrapie-infected transgenic mouse model that expresses a prion
protein lacking the glycophosphatidylinositol membrane anchor.
These mice deposit PrPSc in their hearts (primarily between
myocytes and around capillaries), renal glomerulus, gut, and islets
of Langerhans after scrapie infection, and their blood contained
high levels of scrapie infectivity [31,32]. In our kidney samples, the
majority of PrPSc immunolabeling was observed in the renal
papillae in accordance with previous studies [7]. However, in one
case, granular immunolabeling at a renal corpuscle was observed.
In addition to the rodent model, similar results in the kidney have
been described in an FSE-infected cheetah [33].
In contrast, the number of PrPSc positive samples from urinary
bladder detected was low. This result was expected (2 of 16 were
positive by at least one technique) because infectivity has only been
previously documented in an experimental model [34]. The single
urinary bladder that was positive by both PrPSc detection
techniques belonged to sheep No. 8, which exhibited the greatest
PrPSc distribution throughout its body. This finding suggests that
the urinary bladder is one of the last peripheral organs to be
infected. As observed in the pancreas, the immunolabeling pattern
observed in the urinary bladder was associated with the PNS
components that innervate this organ. Additionally, PrPSc deposits
were associated with PNS structures in the adrenal gland,
mammary gland, skin and skeletal muscle.
In our study, the adrenal gland was the most affected peripheral
organ because in all of the animals this tissue was at least positive
by IHC. In sheep scrapie and other natural TSEs [27,35,36,37],
PrPSc deposition has been documented in the adrenal medulla
associated with nerve fibres. In our samples, the majority of the
Figure 6. Immunohistochemical detection of PrPSc in mammary gland using L42 PrP antibody. A) Mammary gland from a sheep
simultaneously infected by scrapie and by Maedi-visna infection causing a mastitis (x10). PrPSc immunolabeling is located within the lymphofollicular
inflammatory lesions. In the mammary gland acini (arrows) next to the inflammatory lesions no PrPSc immunolabeling can be observed. B) Mammary
gland from an uninfected control sheep with mastitis associated with Maedi-visna infection in which no PrPSc immunolabeling is present (x10). C)
Mammary gland from a naturally scrapie-infected sheep (x10). PrPSc immunolabeling can be observed in the nerves immersed in the interlobular
connective tissue (x10). A detailed image of a nerve fibers bundle in which a periaxonal PrPSc immunolabeling can be observed (arrows) is shown in
the insert picture. D) Mammary gland from an uninfected control sheep in which no PrPSc immunolabeling is present (x20). Cross section of a nerve
fiber is indicated by an arrow.
doi:10.1371/journal.pone.0097768.g006
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PrPSc immunolabeling observed was also found in the medulla;
however, it was associated with chromaffin cells, which are
considered to be modified sympathetic postganglionic neurons.
Recently, a similar pattern has been extensively described in
natural and experimentally infected sheep [38]. In addition to the
medulla, we also detected PrPSc deposits beneath the capsule
associated with ganglion and nerve fibres, as well as in the
suprarenal ganglion that surrounds the gland. To our knowledge,
PrPSc immunolabeling in the adrenal cortex has only been
described in a FSE-infected cheetah [33].
In the skeletal muscle (including the tongue) and the mammary
gland, a periaxonal PrPSc immunolabeling pattern was observed in
the small nerve fibre bundles immersed in the tissue. A similar
immunolabeling pattern associated with Schwann cells has been
described in peripheral nerves in experimentally induced scrapie
infections [39], BSE in primates [40] and BSE in sheep [41]. In
natural TSEs, PrPSc immunolabeling has been reported in muscle
samples and was associated with intramuscular nerve fibres and
muscle spindles in cases of scrapie [6] but was only associated with
nerve fibres in human TSEs [42]. Consistent with Andreoletti et al.
(2004), we observed PrPSc immunolabeling patterns that were
associated with muscle spindles, but only in one sheep (No. 8),
which had the greatest PrPSc distribution throughout its body. In
the rest of the muscle samples, PrPSc immunolabeling was
associated with intramuscular nerve fibres. We detected a higher
number of positive muscle samples than Andreoletti et al. (2004),
most likely because all of our sheep were in an advanced clinical
phase of the disease.
Regarding the skin, the presence of PrPSc has been demon-
strated by WB in natural scrapie infection and by WB, PET blot
and IHC in a rodent model, showing that PrPSc is always
associated with small nerve fibres within the dermis [9]. Although
we have also observed this immunolabeling pattern, we describe
for the first time the presence of PrPSc within the epidermis, which
was most likely associated with free nerve endings. Our findings
confirms the skin as a potential reservoir of prions that could play a
role in the spread of scrapie in the field, as it has been suggested
previously [9] [43].
Figure 7. Immunohistochemical detection of PrPSc in lung and liver using L42 PrP antibody. A) Lung from a sheep infected by scrapie
with a concomitant verminous pneumonia (x10). PrPSc immunolabeling is located within the inflammatory lesions related to the lungworm infection
(x10). Parasites can be observed in the alveoli (asterisk). B) Lung from an uninfected control sheep with verminous pneumonia in which no PrPSc
immunolabeling is present (x10). Parasites can be observed in the alveoli (asterik). C) Liver from a sheep infecetd by scrapie with a concomitant
trematode infection (x10). PrPSc immunolabeling is associated with a lymphofollicular inflammatory site around a bile duct. In the bile duct lumen
adult forms of parasites can be observed (asterisk). D) Liver from an uninfected scrapie sheep with trematode infection in which no PrPSc
immunolabeling is present (x10). In the bile duct lumen, adult forms of parasites can be observed (asterisk).
doi:10.1371/journal.pone.0097768.g007
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We observed an epithelial immunolabeling pattern associated
with sweat glands, lacteal ducts and bronchioles. In some cases, the
topographical location of the immunolabeling (on the basal side of
the epithelium) suggests that this pattern could be associated with
nerve endings. In the case of the mammary gland and sweat
glands, this location could also suggest the immunolabeling of
myoepithelial cells; however, previous reports have shown that
these cells do not express PrPc in the ovine mammary gland
[44,45]. Although natural scrapie infections exhibiting an intra-
cellular immunolabeling pattern associated with the epithelial cells
of the salivary glands have been previously reported [46], we
classified our samples as inconclusive by IHC. Only one sample
exhibiting this exclusive epithelial immunolabeling pattern was
also positive by IDEXX EIA (No. 10; mammary gland); however,
because the samples subjected to IHC and IDEXX EIA were not
the same, we cannot dismiss the possibility that this positive result
could be due to the presence of positive nerve fibre bundles within
the tissue.
A large body of evidence indicates that scrapie infection ascends
from the gut into the thoracic spinal cord and to the medulla
oblongata along the splanchnic and vagus nerves, respectively.
From these initial sites, infection propagates cranially and caudally
within the CNS, which subsequently seems to spread centrifugally
to the sensory ganglia of the vagus and splanchnic circuits (for
review see [17]). PrPSc centrifugal transport from the brain to
further peripheral tissues along peripheral nerves has been
demonstrated mainly in animal models and through intracerebral
inoculation [6,9,47,48]. Our results are in agreement with these
experimental models and suggest that there is a marked spread of
PrPSc from the CNS to other tissues, mainly throughout the PNS
in natural scrapie infections. All of the animals included in the
present study showed a widespread distribution of PrPSc within the
CNS. In peripheral organs, we localised PrPSc to structures
associated with sympathetic efferent nerves (i.e., chromaffin cells in
the adrenal gland), parasympathetic efferent nerves (i.e., neurons
immersed in the pancreatic parenchyma or the urinary bladder
walls) and sensory nerves (i.e., epidermis). PrPSc immunolabeling
observed in nerves within skeletal muscle could be associated with
sensory or somatic motor nerve fibers.
In our study, the pelvic visceral organs (urinary bladder and
reproductive organs) were the least affected. Unlike the abdominal
and thoracic viscera, the cell bodies of the preganglionic
parasympathetic neurons that innervate the pelvic viscera are
located in the sacral spinal cord. In addition, the sensory ganglia
are also associated with this spinal cord segment. Because the
sacral segment is the most caudal region of the spinal cord, the
slow progression of infection from the initial site of CNS invasion
at the thoracic level to the sacral level, and from there to the pelvic
organs, could explain why these are some of the last peripheral
organs to be infected. The rate of spread of the scrapie agent
within the nervous system could also explain why the greatest
PrPSc dissemination is observed in the ARQ/ARQ animals. In the
present study, only 2 VRQ/VRQ sheep were included, but
neither of them exhibited the highest number of positive
peripheral organs. It has been shown that there is a large genetic
influence on the incubation period of scrapie in sheep [49] and it
has been suggested that polymorphisms in the PrP gene may alter
PrPSc accumulation kinetics rather than accumulation sites or
cellular specificity [50]. The progression of PrPSc through the
nervous system could be slower in ARQ/ARQ sheep than in
VRQ/VRQ sheep. Thus, ARQ/ARQ sheep will develop the
disease after a longer incubation period, and they have more time
for PrPSc to spread throughout the PNS. Consistent with this, one
of the oldest animals included in the present study (No. 8; ARQ/
ARQ genotype) showed the greatest PrPSc distribution throughout
its body. Previously, it has been reported that a prolonged
incubation period together with a marked LRS involvement
increases the probability of PrPSc accumulation in sheep kidneys,
although in this case, a hematogenous spreading mechanism was
proposed [7,10]. In contrast, our results suggest that PrPSc
dissemination in the organism does not appear to be influenced
by the degree of LRS involvement because 2 sheep exhibited
several non-lymphoid positive organs, and all of the lymphoid
organs that were studied were negative.
Although the PNS seems to be the main mechanism of PrPSc
dissemination in a host, inflammation or the presence of prions in
the blood may lead to a more widespread and pronounced
accumulation of PrPSc deposits in the body [11]. In addition to
PNS structures, we detected PrPSc immunolabeling associated with
chronic inflammatory lesions. In sheep with naturally acquired
scrapie, PrPSc deposition has been described previously in
abomasum, mammary gland and lung tissue associated with viral
and/or parasitic infections [13,15,51]. However, to our knowl-
edge, this is the first description of the presence of PrPSc in liver
tissue associated with chronic inflammatory lesions in naturally
scrapie-infected sheep. Recently, PrPSc deposition has been
detected in liver tissue with no inflammatory lesions from naturally
infected VRQ/VRQ sheep and was found to be associated with
Kupffer cells [10]. Interestingly, we observed a similar pattern of
immunolabeling in only one sheep which exhibited a VRQ/VRQ
genotype; nevertheless, we could not confirm the presence of PrPSc
by IDEXX EIA. It has been proposed that accumulation of PrPSc
in Kupffer cells and renal papillae results from direct exposure to
prions in the blood [7,10]. The hematogenous spread could also
explain the PrPSc deposits that we observed in the vascular pole of
a renal corpuscle. However, the sympathetic nerve fibres that
reach that zone of the corpuscle and innervate the juxtaglomerular
cells might also explain this renal PrPSc accumulation. Likewise,
the origin of the PrPSc accumulation that we have observed in the
heart remains unclear, and further investigations are needed to
clarify the PrPSc location at a cellular level.
Overall, the results from the present study showed large
variation in peripheral spread of PrPSc among sheep. Although
all of the infected animals included in the study presented a
widespread PrPSc accumulation in the CNS, they did not show a
similar PrPSc dissemination through the PNS. The heterogeneous
distribution of PrPSc-containing nerve fibres within the peripheral
organs in conjunction with the small amounts observed could
explain the variation between animals. This variation has also
been observed in the skeletal muscle [6], kidney [7], liver [10] and
skin [9] of sheep infected with scrapie. It should be highlighted
that only 2 pieces of tissue were collected from fairly big organs,
one for IHC and one for EIA test. Sampling multiple sites within
organs and using more sensitive techniques would most likely
result in a higher number of peripheral positive organs in each
animal, but the study is not intended to be representative in
nature. In addition, the results from the IHC and IDEXX EIA
analyses showed a poor correlation between both techniques, with
a higher number of positive samples observed via IHC in
comparison with the IDEXX EIA. This IDEXX EIA is a
commercial immunoassay for PrPSc detection in nervous or
lymphoid tissues. In the present study, all samples were analysed
and interpreted according to the manufacturer’s cut-off criterion.
In some previous studies that have used commercial ELISA tests
for PrPSc detection in non-nervous or non-lymphoid tissues, the
cut-off value has been recalculated as a function of the type of
tissue analysed (as 3 standard deviations above the mean of the
negative controls [10,41]). The cut off values determined in these
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cases were lower than those set by the manufacturers (i.e., 0.059
for liver samples [10]). Equally, we calculated the cut off for liver,
pancreas and urinary bladder from 10 negative sheep (as 4
standard deviations above the mean) and obtained values of 0.069,
0.040 and 0.063, respectively. If these cut off values were used, all
of the samples that were positive by IHC only, would be confirmed
by IDEXX EIA; however, we would also have 1 positive sample
only by IDEXX EIA in the case of liver tissue, 7 in the pancreas
and 2 in the urinary bladder. Therefore, although it is possible that
by applying the manufacturer’s cut-off criterion we would obtain a
lower IDEXX EIA sensitivity, a more in-depth study is needed to
adapt the cut off value for each individual tissue.
Together with previous reports, the present study indicates that
scrapie infection may spread through the PNS to most, if not all,
parts of the body. The PrPSc presence in non-nervous organs does
not appear to have any additional pathological role but
demonstrates that some of these organs are potentially infectious
(which has not been considered thus far [21]) and generates new
insights into horizontal transmission. In addition, our observations
regarding naturally acquired scrapie may provide indirect
information about the spread of the agent in related TSEs such
as vCJD and CWD.
Supporting Information
Figure S1 Immunolabeling classified as inconclusive by
immunohistochemiestry in mammary gland and lung.
A) Mammary gland from a naturally scrapie-infected sheep (x40).
A granular immunolabeling at the basal side of the epithelium of a
lactiferous duct can be observed. B) A lactiferous duct of a
mammary gland from an uninfected control sheep in which no
immunolabeling is present (x40). C) Lung from a naturally scrapie-
infected sheep (x40). Immunolabeling in the epithelium of a
bronchiole can be observed. D) A bronchiole of a lung from an
uninfected control sheep in which no immunolabeling is present
(x40). The specificity of the epithelial immunolabeling pattern
observed in (A) and (C) could not be confirmed by IDEXX EIA.
(TIF)
Figure S2 Immunolabeling classified as inconclusive by
immunohistochemiestry in liver. A) Liver from a naturally
scrapie-infected sheep (x63). An immunolabeling probably related
to a Kupffer cell (arrow) was observed. This immunolabeling was
detected only in one sample and its specificity could not be
demonstrated because this sample was negative by IDEXX EIA.
B) Liver from an uninfected control sheep in which no
immunolabeling is present (x63). Kupffer cells are indicated by
arrows.
(TIF)
Table S1 Details of control sheep used in the study.
From each animal the identification number, age, flock of origin
and genotype are included.
(DOCX)
Table S2 Individual sheep results of PrPSc detection by
IHC/IDEXX EIA. The OD value obtained by IDEXX EIA is
indicated for samples that were assessed by this technique.
(DOCX)
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